Manufacturing Method at Fault for FluVax Reactions
Around 101 children under five years of age suffered from febrile convulsions after receiving FluVax brand vaccine in 2010. An investigation into the incident revealed the culprit could be the virus particles present in the vaccine, manufactured by CSL Biotherapies.
The vaccine has since been banned for children under five years of age and Professor Chris Baggoley said that other two influenza vaccines have no such problems and parents should get their children vaccinated.
Meanwhile, CSL has said that it could be years before its vaccine is declared safe for use. The company said it needed to show that a new manufacturing method was safe and effective before resuming the use of the vaccine.